What We Do
Our business model is built on strategic partnerships with research & development centres & manufacturing facilities for product development & supplies. Our strength lies in supplying generic finished formulations and APIs.
Cyllpharm’s core expertise is in the area of sales, distribution and marketing of products & services in international markets and offers wide access to markets in the EU, Latin America, Asia Pacific & the Middle East. Product promotion is handled by a team of qualified professionals in the respective markets and well supported by key opinion leaders.
An in-depth knowledge of the varied health care systems, tendering processes, access to supplying to major hospitals and retail chains and robust strategies enhance our value as the partner of choice for distribution companies desiring to augment their product portfolios as well as for manufacturing companies with a vision to launch their products in International markets.
Cyllpharm has strategic arrangements with select manufacturing companies to contract manufacture and supply products encompassing the therapeutic segments of critical care, cardiology, neuropsychiatry, anti diabetics, GI, urology, pain management and contrast media. The manufacturing facilities carry accreditations from renowned regulatory authorities.
The selection of manufacturing facilities is made on the basis of a stringent internal process of due diligence, satisfying that the facilities meet the highest standards of regulatory compliance and the products conform to quality, packaging standards and meet delivery timelines.
Regulatory compliance is a key area for any pharmaceutical company. Cyllpharm’s regulatory team has a deep understanding of the global regulatory requirements and is constantly updated on the new requirements of each market.
The regulatory expertise includes developing product dossiers confirming to EU CTD & ACTD guidelines, audit of supporting manufacturers to satisfy compliance with cGMP, audit of distribution partners for adherence to GDP requirements. Product and plant dossiers are subjected to a thorough scrutiny by the regulatory team to ensure compliance prior to filing with the regulatory authorities, which leads to minimum queries and shorten approval timelines.
Cyllpharm’s formulation development is supported by partner R & D labs skilled in innovation and cost effective technology. The R & D labs provide support in fulfilling the customers needs with their expertise in developing conventional tablets & capsules, novel drug delivery systems, pre-formulation studies, literature search, process characterisation and scale up to commercial facilities.
The product development is ably supported by robust and reproducible analytics.
Cyllpharm offers quality analytical services through its partner companies. The analytical services include the expertise to carry out Nitrosamine studies, Extractable & Leachable studies, in addition to carrying out stability testing including photo stability studies, elemental impurity analysis, method development and validation of impurities at trace levels, generation of data complaint to regulatory submissions.